Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Antibody-mediated Transplant Rejection”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Not applicableLooking for participantsNCT07006532
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab

Who this might be right for
Kidney Transplant Rejection
Shahid Beheshti University of Medical Sciences 50
Not applicableUnknownNCT03436134
What this trial is testing

Treatment of Chronic Active Antibody Mediated Rejection After Kidney Transplantation by Double-Filtration PlasmaPheresis or Plasma Exchange

Who this might be right for
Kidney TransplantationAntibody Mediated Rejection
University Hospital, Grenoble 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT03380962
What this trial is testing

Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant

Who this might be right for
Kidney Failure, ChronicEnd-Stage Renal DiseaseTransplant Glomerulopathy+4 more
Stanley Jordan, MD 20
Not applicableActive Not RecruitingNCT03859388
What this trial is testing

Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection

Who this might be right for
Rejection Chronic RenalKidney Transplant Rejection
Cedars-Sinai Medical Center 10
Not applicableLooking for participantsNCT04870437
What this trial is testing

Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During Chronic AntiBody-Mediated Rejection in Kidney Transplantation.

Who this might be right for
Kidney Transplantation
University Hospital, Angers 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06886646
What this trial is testing

Allogeneic Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation

Who this might be right for
Chronic Antibody-mediated Rejection (cABMR)
Assistance Publique - Hôpitaux de Paris 22
Not applicableUnknownNCT04414735
What this trial is testing

Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Fundacion Clinic per a la Recerca Biomédica 30
Large-scale testing (Phase 3)Ended earlyNCT03744910
What this trial is testing

Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
CSL Behring 194
Testing effectiveness (Phase 2)Study completedNCT02201576
What this trial is testing

Bortezomib in Rejection of Kidney Transplants

Who this might be right for
Chronic Antibody-mediated Transplant Rejection
Assistance Publique - Hôpitaux de Paris 60
Testing effectiveness (Phase 2)Looking for participantsNCT06503731
What this trial is testing

Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)

Who this might be right for
Antibody-mediated Rejection
argenx 30
Not applicableStudy completedNCT04057742
What this trial is testing

AlloSure for the Monitoring of Antibody Mediated Processes After Kidney Transplantation

Who this might be right for
Kidney Transplant Failure and Rejection
University of Wisconsin, Madison 52
Not applicableStudy completedNCT02147210
What this trial is testing

Chronic Transplant Glomerulopathy and Regulation of Expression of Ephrin B1

Who this might be right for
Kidney Transplantation
University Hospital, Toulouse 60
Testing effectiveness (Phase 2)UnknownNCT02563340
What this trial is testing

Effect of BM-MSCs on Chronic AMR After Kidney Transplantation

Who this might be right for
Kidney Transplantation
First Affiliated Hospital, Sun Yat-Sen University 60
Not applicableStudy completedNCT03474536
What this trial is testing

Quantitative Parameters of HLA-DQ Antibodies in Lung Transplantation

Who this might be right for
Lung TransplantationAntibody Mediated RejectionChronic Lung Allograft Dysfunction
University Hospital, Bordeaux 88
Not applicableActive Not RecruitingNCT07316829
What this trial is testing

TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS

Who this might be right for
Graft RejectionKidney TransplantationLung Transplantation+6 more
Fondazione IRCCS Policlinico San Matteo di Pavia 30
Not applicableActive Not RecruitingNCT03719339
What this trial is testing

VIRTUUS Children's Study

Who this might be right for
Renal Transplant RejectionPediatric Kidney DiseaseEnd Stage Renal Disease+4 more
Children's Hospital of Philadelphia 445
Testing effectiveness (Phase 2)Study completedNCT02426684
What this trial is testing

Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation

Who this might be right for
Renal Disease
Cedars-Sinai Medical Center 17
Large-scale testing (Phase 3)Looking for participantsNCT04561986
What this trial is testing

TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

Who this might be right for
Antibody-mediated Rejection
Vastra Gotaland Region 50
Large-scale testing (Phase 3)Study completedNCT00275509
What this trial is testing

Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch

Who this might be right for
Kidney Failure, Chronic
Johns Hopkins University 56
Not applicableEnded earlyNCT03585855
What this trial is testing

Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Antibody Mediated Kidney Graft Rejection (ABMR)

Who this might be right for
Interventional
University Medical Centre Ljubljana 4
Load More Results